Unlock stock picks and a broker-level newsfeed that powers Wall Street.
5.53
-0.05
(-0.90%)
At close: 4:00:01 PM EDT
5.38
-0.15
(-2.71%)
After hours: 4:07:14 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 9 | 9 | 11 | 9 |
Avg. Estimate | -0.51 | -0.49 | -2.01 | -1.97 |
Low Estimate | -0.56 | -0.58 | -2.28 | -2.99 |
High Estimate | -0.43 | -0.33 | -1.49 | -1.5 |
Year Ago EPS | -0.37 | -0.45 | -1.83 | -2.01 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 10 | 10 | 12 | 9 |
Avg. Estimate | -- | -- | -- | 3.97M |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | 32.87M |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -0.43 | -0.41 | -0.47 | -0.51 |
EPS Actual | -0.37 | -0.45 | -0.49 | -0.51 |
Difference | 0.06 | -0.04 | -0.02 | -0 |
Surprise % | 13.79% | -10.90% | -3.89% | -0.32% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.51 | -0.49 | -2.01 | -1.97 |
7 Days Ago | -0.51 | -0.49 | -1.96 | -1.94 |
30 Days Ago | -0.52 | -0.51 | -2.11 | -2.32 |
60 Days Ago | -0.52 | -0.5 | -2.12 | -2.24 |
90 Days Ago | -0.52 | -0.51 | -2.11 | -2.1 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | -- | -- |
Up Last 30 Days | 1 | 1 | 3 | 4 |
Down Last 7 Days | -- | -- | -- | 1 |
Down Last 30 Days | 1 | 1 | 4 | 2 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ORIC | -38.14% | -9.63% | -9.59% | 1.85% |
S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
Reiterates | Guggenheim: Buy to Buy | 2/26/2025 |
Maintains | JP Morgan: Overweight to Overweight | 2/26/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 2/26/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 2/24/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 2/21/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 2/11/2025 |
Related Tickers
ERAS Erasca, Inc.
1.2050
-12.04%
IDYA IDEAYA Biosciences, Inc.
14.77
-9.83%
OLMA Olema Pharmaceuticals, Inc.
3.3400
-11.17%
NRIX Nurix Therapeutics, Inc.
10.47
-11.87%
RVMD Revolution Medicines, Inc.
33.62
-4.92%
KYMR Kymera Therapeutics, Inc.
25.24
-7.80%
MAZE Maze Therapeutics, Inc.
9.90
-10.08%
RAPT RAPT Therapeutics, Inc.
1.1700
-4.10%
DNTH Dianthus Therapeutics, Inc.
16.83
-7.22%
KROS Keros Therapeutics, Inc.
9.55
-6.28%